Français Néerlandais Japonais Chinois Allemand Espagnol Portugais

COVID: Healthcare companies swing into action in Hauts-de-France

07 May 2020 | Front page, Health Nutrition, Investment

Unlike other sectors, it's been business as usual for healthcare companies in Hauts-de-France as they have continued their activity and even started preparing for the easing of lockdown; SGD Pharma is a prime example.

Pharmaceuticals, Vygon, AstraZeneca, SGD Pharma, covid, lockdown

AstraZeneca: tools for patients with chronic conditions

Based in Hauts-de-France, the Anglo-Swedish group AstraZeneca is actively involved in the global fight against COVID, providing expertise in the search for monoclonal antibodies.

The group has developed several initiatives on a national scale:

  • Ensuring continuity of products and services to patients with chronic conditions who may be more susceptible to the virus;
  • Developing telemedical services (in the form of a mobile app) which allow cancer patients to be monitored remotely. Find out more, read the press release;
  • Launching the Innovation and Health Coalition in partnership with 3 other companies (France Biotech, MedTech in France and France Digitale). It now consists of around 40 stakeholders in the healthcare sector, including GSK which is also has a base in Hauts-de-France. The coalition aims to foster innovative development, responding to the needs of health professionals and patient groups.
    Visit the Coalition’s website

    A collaboration between healthcare companies and a partnership created by GSK and Sanofi.

Increased activity at SIPA

In contrast to many companies, the Industrial Plastics Company of Avesnes, “SIPA”, (part of the French group Vygon), has seen orders increase fourfold since the onset of the health crisis.

What does it produce? The Bougie Boussignac, a device that allows people in respiratory distress to be intubated, while continuing to be ventilated.

To cope with this increase (production has shot from three thousand units per month to between ten and fifteen thousand), the company has had to boost its workforce by the equivalent of ten full-time employees.

Meanwhile, SGD Pharma is investing for the post-pandemic era

Like many companies in the sector, the Chinese SGD Pharma Group has been involved in the wave of national solidarity by providing protective equipment to medical personnel.

Today, the pharmaceutical packaging specialist is preparing for the easing of lockdown and it anticipates an increase in demand with more stringent requirements, as well as more competition within the industry. In order to adapt its manufacturing facilities and increase production of vaccine bottles, the group plans to inject €37 million, of the total €45M for its 5 plants, into its two French factories, including the Saint-Quentin-Lamotte site in Hauts-de-France.

"We will need to vaccinate the planet! This will only be possible if the medical industry has the necessary active ingredients, excipients and containers," explains Christophe Nicoli, CEO of SGD Pharma.

Sources: BFM TV, AstraZeneca, Les Echos, La Voix du Nord

Back to news

News

NutrEvent, the unmissable Nutrition and Health event

The European Nutrition and Health event returns to Lille on 20 and 21 October around the theme of “One Health”. Why should you attend?

COVID19: Lille’s Pasteur Institute joins the fight

In Hauts-de-France, the fight against COVID19 involves research. A team from Lille’s Pasteur Institute has been working hard to find a cure since the beginning of the crisis.

All news